Hypertension, chronic kidney disease, and the development of cardiovascular risk: A joint primacy

Kidney International

Volumn 77, Issue 9, 2010, Pages 753-755

  Middleton, John P ^a   Pun, Patrick H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL WALL THICKNESS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INFLAMMATION; NOTE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; UREMIA;

EID: 77951064437     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.19     Document Type: Note

References (18)

1. Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
2. Go AS, Chertow GM, Fan D et al.Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
3. United States Renal Data System. 2009 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, Maryland, USA, 2009.
4. Pun PH, Smarz TR, Honeycutt EF et al. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int 2009; 76: 652-658.
5. Rump LC, Amann K, Orth S et al. Sympathetic over-activity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 2000; 15: 1735-1738.
6. Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001; 38: S11-S17.
7. Parekh RS, Planting a LC, Kao WH et al. The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int 2008; 74: 1335-1342.
8. Pun PH, Lehrich R, Honeycutt E et al. Risk factors associated with sudden cardiac arrest in hemodialysis patients: a case-control study. J Am Soc Nephrol 2008; 19: 728-729A.
9. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
10. Agarw al R, Pe ixoto A J, Santos S F, et al.Out-of-office blood pressure monitoring in chronic kidney disease. Blood Press Monit 2009; 14: 2-11.
11. Foley RN. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 2003; 16: 111-117.
12. Paoletti E, Specchia C, Di Maio G et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 2004; 19: 1829-1834.
13. Kendrick J, Chonchol M, Gnahn H et al. Higher systolic blood pressure is associated with progression of carotid intima-media thickness in patients with chronic kidney disease. Kidney Int 2010; 77: 794-800.
14. Färbom P, Wahlstrand B, Almgren P et al. Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the Nordic Diltiazem Study. Hypertension 2008; 52: 115-122.
15. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
16. Sarafidis PA, Li S, Chen SC et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med 2008; 121: 332-340.
17. Plantinga LC, Miller III ER, Stevens LA et al. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension 2009; 54: 47-56.
18. Norris K, Bourgoigne J, Gassman J et al. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis 2006; 48: 739-751. (Pubitemid 44740048)